CT-1 is a member of the IL-6 family of cytokines which also includes LIF, CNTF, OSM (Oncostatin M), IL-11, IL-6 and possibly NNT-1/BSF-3. CT-1 is a pleiotropic cytokine which is expressed in various tissues including the adult heart, skeletal muscle, ovary, colon, prostate and fetal lung, and signals through the LIF receptor and the gp130 receptor subunit. CT-1 has the ability to induce cardiac myocyte hypertrophy, and enhances the survival of cardiomyocyte and different neuronal populations. Biologically active human CT-1 is synthesized as a 201 amino acid polypeptide lacking a hydrophobic N-terminal secretion signal sequence.
- Species: Human
- Expression: E. coli Cell Expressed
- Activity: Typically ≤ 1.0 ng/ml ED50
- Purity: ≥98%
- Endotoxin: <1.0 EU/μg
- Molecular Mass: 21.1 kDa
- Formulation: 1x PBS
- Country of Origin: USA
This was determined by SDS-PAGE gel and HPLC analysis.
Determined by its ability to stimulate the proliferation of human TF-1 cells.
Centrifuge the vial prior to opening. Reconstitute in 20mM Tris, pH 8.0 to a concentration of ≤ 1.0 mg/ml. Do not vortex.
This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% HSA) and store in working aliquots at -20°C to -80°C.